Bank of Montreal
IBRN icon

Bank of Montreal’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History

Bank of Montreal’s Portfolio IBRN Stock Details IBRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,300
Closed -$32.4K – 3729
2024
Q3 		$32.4K Buy
1,300
+566
+77% +$14.2K ﹤0.01% 3497
2024
Q2 		$17.3K Sell
734
-1,516
-67% -$35.9K ﹤0.01% 3599
2024
Q1 		$58.5K Buy
+2,250
New +$58K ﹤0.01% 3413

Other funds holding IBRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Bank of Montreal's IBRN Position: Q4 2024 in Review

Bank of Montreal sold out of iShares Neuroscience and Healthcare ETF (IBRN) in Q4 2024, closing a stake of 1,300 shares — an estimated $32.4K sold.

Bank of Montreal first reported a position in IBRN in Q1 2024 and held it in 3 quarters. The position peaked at $58.5K in Q1 2024. 2 funds tracked by Wall St. Rank hold IBRN as of Q4 2024.

  • Bank of Montreal reported no remaining iShares Neuroscience and Healthcare ETF position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 1,300 iShares Neuroscience and Healthcare ETF shares in Q4 2024, an estimated $32.4K.
  • Bank of Montreal first reported a position in iShares Neuroscience and Healthcare ETF in Q1 2024 and held it in 3 quarters.
  • Bank of Montreal's iShares Neuroscience and Healthcare ETF position peaked at $58.5K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.